Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Bente Glintborg; Mikkel Østergaard; Lene Dreyer; Niels Steen Krogh; Ulrik Tarp; Michael Sejer Hansen; Signe Rifbjerg-Madsen; Tove Lorenzen; Merete Lund Hetland

doi:10.1002/art.30117

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Bente Glintborg, Mikkel Østergaard, Lene Dreyer, Niels Steen Krogh, Ulrik Tarp, Michael Sejer Hansen, Signe Rifbjerg-Madsen, Tove Lorenzen, Merete Lund Hetland

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

207 Citationer (Scopus)

Abstract

To investigate disease activity, treatment response, and drug survival, and predictors thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment series with a tumor necrosis factor α (TNFα) inhibitor.

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	63
Udgave nummer	2
Sider (fra-til)	382-390
Antal sider	9
ISSN	0004-3591
DOI	https://doi.org/10.1002/art.30117
Status	Udgivet - 2011
Udgivet eksternt	Ja

Adgang til dokumentet

10.1002/art.30117

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Glintborg, B., Østergaard, M., Dreyer, L., Krogh, N. S., Tarp, U., Hansen, M. S., Rifbjerg-Madsen, S., Lorenzen, T., & Hetland, M. L. (2011). Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry. Arthritis & Rheumatism, 63(2), 382-390. https://doi.org/10.1002/art.30117

@article{840a2aae667f461d93d8c3b1743137df,

title = "Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry",

abstract = "To investigate disease activity, treatment response, and drug survival, and predictors thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment series with a tumor necrosis factor α (TNFα) inhibitor.",

author = "Bente Glintborg and Mikkel {\O}stergaard and Lene Dreyer and Krogh, {Niels Steen} and Ulrik Tarp and Hansen, {Michael Sejer} and Signe Rifbjerg-Madsen and Tove Lorenzen and Hetland, {Merete Lund}",

year = "2011",

doi = "10.1002/art.30117",

language = "English",

volume = "63",

pages = "382--390",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "Wiley",

number = "2",

}

Glintborg, B, Østergaard, M, Dreyer, L, Krogh, NS, Tarp, U, Hansen, MS, Rifbjerg-Madsen, S, Lorenzen, T & Hetland, ML 2011, 'Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry', Arthritis & Rheumatism, bind 63, nr. 2, s. 382-390. https://doi.org/10.1002/art.30117

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry. / Glintborg, Bente; Østergaard, Mikkel; Dreyer, Lene et al.
I: Arthritis & Rheumatism, Bind 63, Nr. 2, 2011, s. 382-390.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy

T2 - Results from the nationwide Danish DANBIO registry

AU - Glintborg, Bente

AU - Østergaard, Mikkel

AU - Dreyer, Lene

AU - Krogh, Niels Steen

AU - Tarp, Ulrik

AU - Hansen, Michael Sejer

AU - Rifbjerg-Madsen, Signe

AU - Lorenzen, Tove

AU - Hetland, Merete Lund

PY - 2011

Y1 - 2011

N2 - To investigate disease activity, treatment response, and drug survival, and predictors thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment series with a tumor necrosis factor α (TNFα) inhibitor.

AB - To investigate disease activity, treatment response, and drug survival, and predictors thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment series with a tumor necrosis factor α (TNFα) inhibitor.

U2 - 10.1002/art.30117

DO - 10.1002/art.30117

M3 - Journal article

SN - 0004-3591

VL - 63

SP - 382

EP - 390

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 2

ER -